Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

How I treat HIV-associated multicentric Castleman disease

(2010) M. Bower   BLOOD

The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease

(2009) T. Powles et al.   ANNALS OF ONCOLOGY

Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease

(2009) Mark Bower et al.   BLOOD

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

(2009) Kenneth R Carson et al.   LANCET ONCOLOGY

HIV-associated multicentric Castleman's disease

(2008) Justin Stebbing et al.   AMERICAN JOURNAL OF HEMATOLOGY

The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease

(2008) J. Stebbing et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

HIV/AIDS: Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma–Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease

(2008) Ryan J. Sullivan et al.   CLINICAL INFECTIOUS DISEASES

Human herpesvirus 8 DNA quantification in matched plasma and PBMCs samples of patients with HHV8-related lymphoproliferative diseases

(2008) Rosamaria Tedeschi et al.   JOURNAL OF CLINICAL VIROLOGY